Microcrystalline Cellulose (MCC) in Pharmaceuticals: Properties, Variability and Characterization

Microcrystalline cellulose is generally regarded as a chemically stable and relatively inert pharmaceutical excipient. However, this does not mean that every MCC material is chemically inert toward every active pharmaceutical ingredient (API). In formulations containing a susceptible drug substance, relatively small differences in the chemical composition, surface properties or moisture behaviour of MCC may become relevant to drug product stability. This is particularly important because the attributes responsible for an API–excipient interaction may not be part of routine pharmacopoeial specifications. Two MCC materials can therefore comply with the same pharmacopoeial requirements while differing in low-level characteristics that influence the stability of a particular API.

Why MCC Reactivity May Only Become Apparent During Stability Studies

The presence of residual sugars, oxidized cellulose structures, organic acids, reactive carbonyl compounds or other low-level components does not mean that an MCC material is unsuitable for pharmaceutical use. MCC has a long history of successful pharmaceutical application and, for most formulations, these components will have no meaningful effect. Problems can arise when the chemical sensitivity of a particular API intersects with a specific material attribute of the excipient. An API–MCC interaction may therefore only become apparent after weeks or months of storage, particularly under elevated temperature or humidity. The first indication may be an unexpected increase in a degradation product, discoloration, a change in impurity profile or a difference in stability between otherwise comparable drug product batches. Different MCC grades, batches or suppliers may also behave differently. Consequently, when unexplained API degradation is observed during stability studies, or when stability changes following a change in MCC grade or supplier, excipient-related reactivity should be considered as one of the potential contributing factors.

Residual Carbohydrates and Reducing Components

Depending on the botanical source and manufacturing history, MCC may contain low levels of residual hemicellulose-derived carbohydrates and other reducing components. Residual sugars such as glucose, xylose, mannose, galactose and arabinose can originate from the lignocellulosic raw material and its subsequent purification and hydrolysis. Reducing sugars contain, or can generate, reactive carbonyl functionality. Reducing cellulose chain ends can provide similar functionality. Although these components may be present only at low levels, they can become relevant when the API contains susceptible functional groups. A well-known example is Maillard-type chemistry between reducing carbohydrates and compounds containing suitable amino groups. Such reactions can result in the formation of drug–excipient interaction products, discoloration and, depending on the system, secondary degradation reactions. Susceptibility depends not only on the concentration of reducing components, but also on API structure, temperature, moisture and the degree of physical contact between API and excipient. This illustrates an important principle in excipient compatibility: the chemical behaviour of an MCC material towards a particular API may be influenced by low-level components rather than by the bulk cellulose itself.

Oxidized Cellulose and Reactive Functional Groups

Cellulose can undergo oxidation during raw-material processing, purification, manufacture or subsequent handling. Oxidation of hydroxyl groups within the glucose units can introduce carbonyl and carboxyl functionalities, resulting in oxidized cellulose structures commonly referred to as oxycellulose. The chemistry of oxidized cellulose is complex because oxidation can occur at different positions within the glucose units and may be accompanied by cleavage or degradation of the cellulose backbone. Oxycellulose therefore represents a range of chemically modified cellulose structures rather than a single defined impurity. From a pharmaceutical perspective, the introduction of carbonyl and other reactive functional groups is particularly relevant because it can alter the chemical reactivity of the excipient. The amount and nature of oxidized cellulose can depend on the raw material, purification process, exposure to oxidizing conditions and subsequent storage. Differences in oxidative history may therefore contribute to chemical variability between MCC grades, batches and suppliers.

Low-Molecular-Weight Degradation Products

The acidic, alkaline, oxidative and thermal conditions encountered during cellulose purification and MCC manufacture can also promote carbohydrate degradation. Depending on the processing conditions, degradation products may include low-molecular-weight organic acids, such as formic and acetic acid, as well as carbonyl-containing compounds and furan derivatives such as 5-hydroxymethylfurfural (HMF) and furfural. These components are chemically different from the high-molecular-weight cellulose itself and may have greater mobility and reactivity within a formulation. Their presence and concentration can depend on raw-material composition, manufacturing conditions and subsequent storage. Low-molecular-weight reactive components can therefore be important even when they represent only a very small fraction of the total excipient. For a chemically sensitive API, drug product stability may be influenced by the concentration of a reactive trace component rather than by the chemical identity of the bulk excipient.

Formic Acid and Formylation Reactions

Formic acid is of particular interest because it can arise from carbohydrate degradation and has been implicated in specific drug–excipient incompatibilities. For drug substances containing susceptible amine functionality, N-formylation can represent a potential degradation pathway. Mechanistic pharmaceutical studies have demonstrated that formic acid generated from MCC or residual reducing carbohydrates can contribute to the formation of N-formyl degradation products under appropriate conditions. This provides a clear example of why detailed excipient characterization can be relevant to stability investigations: the species responsible for an observed degradation pathway may be a low-level reactive component originating from the excipient rather than the major excipient component itself.

Nitrite in microcrystalline cellulose

Nitrite is of particular interest because trace levels may be present in pharmaceutical excipients and can vary between excipient types, suppliers and batches. For drug substances containing susceptible amine functionality, nitrite can act as a source of nitrosating species and thereby contribute to the formation of N-nitrosamines, including nitrosamine drug substance-related impurities (NDSRIs), under appropriate conditions. This potential contribution can be relevant even at low nitrite concentrations, particularly for excipients such as MCC that are used at relatively high levels in oral solid dosage forms. This provides another example of why detailed excipient characterization can be relevant to drug-product stability and impurity investigations: a low-level reactive component originating from an excipient may contribute to the formation of a critical degradation product. Trace-level nitrite and nitrate analysis can therefore support nitrosamine risk assessment and the comparison of excipient suppliers and batches.

Moisture as a Driver of MCC-Related Stability

MCC interacts readily with environmental moisture, and the amount and state of water associated with the material can influence drug product stability. Moisture can increase molecular mobility and facilitate the transport of reactive species within a solid formulation. It can also enable hydrolytic or other solution-mediated reactions and influence reactions involving residual sugars, organic acids or other reactive components. Consequently, MCC materials with different moisture contents, moisture sorption behaviour or water-binding characteristics may affect a moisture-sensitive API differently, even when both materials comply with applicable pharmacopoeial requirements. The relationship between MCC and API stability can therefore depend strongly on storage temperature and relative humidity. This helps explain why an incompatibility may not be evident during initial formulation studies but becomes apparent during accelerated or long-term stability testing.

Surface Chemistry and the Local Microenvironment

Bulk measurements do not necessarily describe the chemical environment experienced by an API at the surface of an excipient particle. In a solid dosage form, API and MCC particles can be in intimate contact, creating local microenvironments at the API–excipient interface. Surface acidity, adsorbed water, residual processing components and reactive functional groups may influence this local environment. This can be particularly relevant for APIs susceptible to acid- or base-catalysed degradation. Differences between commercial MCC materials may therefore not always be adequately described by conventional bulk measurements such as aqueous pH. When investigating an API–MCC incompatibility, the chemical characteristics of the excipient surface and the local API–excipient environment may also need to be considered.

Oxidative and Processing-Related Reactivity

Oxidative mechanisms may also be relevant for oxidation-sensitive APIs. Although MCC is not generally considered a major source of peroxide impurities compared with excipients particularly susceptible to autoxidation, oxidative degradation should not automatically be excluded when investigating an unexplained stability problem. Pharmaceutical processing itself may also influence excipient reactivity. Mechanical stress can alter particle surfaces, and mechanically generated radicals associated with MCC have been implicated in API degradation during high-shear processing. Manufacturing history and drug product processing conditions may therefore need to be considered alongside the properties of the starting excipient.

Investigating MCC-Related Drug Product Stability Problems

When MCC is suspected of contributing to API degradation, simply repeating routine pharmacopoeial testing may not identify the underlying cause. The investigation should instead be guided by the chemistry of the API and the observed degradation pathway. For an amine-containing API, residual reducing carbohydrates, reactive carbonyl compounds and organic acids may be particularly relevant. For an oxidation-sensitive API, oxidative species and processing history may require consideration. For a hydrolytically sensitive API, moisture content and moisture sorption behaviour may be more important, while acid- or base-sensitive APIs may require investigation of surface chemistry and the local microenvironment. Targeted characterization may therefore include residual carbohydrate profiling, reducing power, reactive functional groups, oxidized cellulose structures, organic acids and other degradation products, together with relevant physical and moisture-related characteristics. Comparing multiple MCC batches, grades or suppliers can be particularly informative because correlations between excipient characteristics and API degradation can help identify the material attribute responsible for the observed stability difference.

The objective is not simply to demonstrate that two MCC materials are analytically different. It is to determine which difference is mechanistically relevant to the degradation pathway of the drug substance. This problem-oriented approach can provide information beyond routine pharmacopoeial testing and support root-cause investigations, excipient selection, supplier qualification, formulation development and the mitigation of excipient-related drug product stability problems.